Vor Biopharma's total assets for Q3 2025 were $176.24M, a decrease of -14.19% from the previous quarter. VOR total liabilities were $2.40B for the fiscal quarter, a 40.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.